Sweet Peach Founder Speaks: Those Startup Dudes Were Wrong About My Company
By Jeff Bercovici,
Inc
| 11. 21. 2014
Untitled Document
When I wrote earlier this week about a new probiotic supplement called Sweet Peach engineered to make women's vaginas smell like fruit, the response across the internet was understandable outrage: Who the hell were the guys behind this and what right did they have to decide how women's bodies ought to smell?
But the true story of Sweet Peach is outrageous in a different way. It turns out that the "startup dudes" who introduced it to the world at the DEMO tech conference, biotech entrepreneurs Austen Heinz and Gilad Gome, are not its creators, and the way they characterized it was highly misleading.
The sole founder and CEO of Sweet Peach Probiotics is a 20-year-old woman named Audrey Hutchinson. A former college student at Bard, where she studied on a full-ride Distinguished Scientist scholarship, she describes herself as an "ultrafeminist" who dropped out to pursue her vision of helping women manage their reproductive health without the need for doctors or clinics. "I don't think women should have vaginas that smell like peaches or anything like that," she...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...